@article {1793,
	title = {HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.},
	journal = {Lancet},
	volume = {368},
	year = {2006},
	month = {2006 Aug 5},
	pages = {451-8},
	abstract = {Highly active antiretroviral therapy (HAART) for the treatment of HIV infection was introduced a decade ago. We aimed to examine trends in the characteristics of patients starting HAART in Europe and North America, and their treatment response and short-term prognosis.},
	keywords = {Adolescent, Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Europe, Female, HIV Infections, HIV-1, Homosexuality, Male, Humans, Male, Multicenter Studies as Topic, North America, Prognosis, Risk-Taking, Time Factors},
	issn = {1474-547X},
	doi = {10.1111/j.1530-0277.2011.01601.x},
	author = {May, Margaret T and Sterne, Jonathan A C and Costagliola, Dominique and Sabin, Caroline A and Phillips, Andrew N and Justice, Amy C and Dabis, Fran{\c c}ois and Gill, John and Lundgren, Jens and Hogg, Robert S and de Wolf, Frank and F{\"a}tkenheuer, Gerd and Staszewski, Schlomo and d{\textquoteright}Arminio Monforte, Antonella and Egger, Matthias}
}
